TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›CRVL
CRVL logo

CRVL

CORVEL CORP

Next earnings Aug 3, 2026

Last earnings +9.2% on 2026-05-20

Buy
$64.14
▲ +4.04%
$64.14▼ -38.08%
over 1Y
L $46.00H $104.34
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.0%
1W+3.8%
1M+11.3%
3M+17.8%
YTD-2.4%
1Y-38.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B
Valuation
Fair value
Filings
Watch
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••

Quality compounder: 28% ROE, accelerating EPS growth, fortress balance sheet — full but defensible at 28.8x P/E.

Revenue $959M · FY2026

The read

Solid fundamentals at a roughly fair price — reasonable risk/reward at today's level.

CorVel is a textbook quality compounder hiding inside the workers' comp services niche. FY2026 results show all the right inflections: revenue $959M (+7.0%) translated into net income of $110M (+16.0%) and diluted EPS of $2.14 (+16.9%), confirming operating leverage as gross profit (+11.0%) and net income each outgrew the top line. Net margin expanded to 11.5% from ~10.6%, ROE is a standout 28.0%, and the five-year revenue trajectory ($646M → $959M) shows uninterrupted growth through varied macro conditions.

The balance sheet is fortress-grade and getting stronger. Cash jumped 36.6% to $233M, equity grew 22.4% to $394M, liabilities/equity is a conservative 0.63x, and there is no funded debt commentary in the MD&A — risk discussion focuses on interest-rate exposure of the cash portfolio, not borrowings, and management explicitly notes that claim-payment liability stays with self-insured clients so credit risk is minimal. Operating cash flow of $156M comfortably covered $45.4M capex and a $56.2M buyback (+49.5% YoY), and share count fell 1.3% — capital returns are accelerating without leverage.

Is CRVL a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread (wide)~90d expiry
  • Long call 64 @ ~6.69 est
  • Short call 74 @ ~3.16 est
debit $353max +$647max −$353BE 67.53

High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25FY26
Revenue$646M$719M$795M$896M$959M
Gross profit$152M$158M$172M$210M$233M
Operating income—————
Net income$66.4M$66.4M$76.3M$95.2M$110M
Diluted EPS$3.66$1.26$1.47$1.83$2.14
Net margin10.3%9.2%9.6%10.6%11.5%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$3.04B
EV / EBITDA—
EV / Sales3.2
EV / FCF27.6
P / FCF29.7
PEG (trailing)1.88
Earnings yield3.4%
FCF yield3.4%

Quality & risk

ROIC (est.)—
Free cash flow$110M
Total debt—
Net cash$233M
Piotroski F-Score6/8

Capital returns

Buyback yield1.7%
Dividend yield (est.)—
Shareholder yield1.7%
Shares Δ YoY-1.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. DEF 14A Proxy statement2026-06-26
  2. 8-K Officer / director change2026-06-01
  3. 10-K Annual report2026-05-22
  4. 8-K Earnings results2026-05-20
  5. 10-Q Quarterly report2026-02-05
  6. 8-K Earnings results2026-02-03
  7. 10-Q Quarterly report2025-11-06
  8. 8-K Earnings results2025-11-04
  9. 8-K Officer / director change2025-09-12

Recent filings

all on EDGAR ↗
ARSPeriod ending 2026-03-312026-06-26open ↗DEFA14AFiling2026-06-26open ↗DEF 14APeriod ending 2026-08-062026-06-26open ↗4Period ending 2026-06-122026-06-15open ↗4Period ending 2026-06-122026-06-15open ↗4Period ending 2026-06-112026-06-12open ↗144Filing2026-06-12open ↗4Period ending 2026-06-092026-06-11open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-082026-06-09open ↗144Filing2026-06-09open ↗144Filing2026-06-08open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueC+
GrowthB+
ProfitabilityA-
Financial healthA-
MomentumD
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$60.58

Fairly valued -6% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.14 × (8.5 + 1.5 × 11.5% growth) × 1.10 quality = 28.3× multiple. An estimate, not a price target.

46.0052-week100.00
Revenue
$959M
+7.0% YoY
Net margin
11.5%
ROE
28.0%
P/E
30.0

SEC fundamentals · FY 2026

'22'23'24'25'26

■ revenue · ■ net income, by fiscal year

Revenue$959M+7.0%
Net income$110M+16.0%
Gross profit$233M+11.0%
Diluted EPS$2.14+16.9%
Cash & equivalents$233M+36.6%
Total assets$643M+17.8%
Total liabilities$249M+11.1%
Stockholders' equity$394M+22.4%
Gross: 24.3%L/E: 0.63x

Frequently asked

Is CORVEL CORP (CRVL) a buy?
CRVL currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Quality compounder: 28% ROE, accelerating EPS growth, fortress balance sheet — full but defensible at 28.8x P/E.
What is CRVL's fair value?
A Modified-Graham model based on CRVL's SEC fundamentals estimates a fair value of about $60.58. It is an estimate from reported earnings, not a price target.
Is CRVL overvalued or undervalued?
Against a Modified-Graham fair-value estimate, CRVL currently appears fairly valued relative to its SEC-grounded earnings power.
What is CORVEL CORP's quality score?
CRVL scores 71.30806163828062/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000874866, latest 10-K filed 2026-05-22) · EODHD · Proprietary analysis · as of 6/25/2026, 1:50:11 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:50 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 10 sales

2026-06-12
Combs Michael G
CEO & President
Sell500.00 @ $60.79$30.4K
2026-06-12
Shishin Maxim
Chief Information Officer
Exercise2.25K @ $52.65$118K
2026-06-12
Shishin Maxim
Chief Information Officer
Sell2.25K @ $60.59$136K
2026-06-11
JESSUP R JUDD
Director
Exercise9.00K @ $14.44$130K
2026-06-11
JESSUP R JUDD
Director
Tax2.15K @ $60.79$131K
2026-06-11
Combs Michael G
CEO & President
Sell7.00K @ $60.55$424K
2026-06-10
Combs Michael G
CEO & President
Sell7.00K @ $61.38$430K
2026-06-09
Combs Michael G
CEO & President
Sell7.00K @ $60.90$426K
2026-06-09
MICHAEL JEFFREY J
Director
Exercise9.00K @ $14.44$130K
2026-06-09
MICHAEL JEFFREY J
Director
Sell9.00K @ $60.98$549K
2026-06-08
Combs Michael G
CEO & President
Sell7.00K @ $60.22$422K
2026-05-26
Yoss Jennifer
Vice President of Accounting
Exercise958.00 @ $52.00$49.8K

Held by tracked funds

Form 13F · SEC · quarterly
Renaissance Technologies1.62M sh$88.4M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Earnings history

beat/miss · move
2026-05-20—▲ +3.28%8-K ↗
2026-02-03—▼ -29.20%8-K ↗
2025-11-04—▲ +2.73%8-K ↗
2025-08-05—▼ -3.43%8-K ↗
2025-05-22—▼ -1.51%8-K ↗
2025-02-04—▲ +6.16%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score71 vs 67
Revenue growth7.0% vs 7.5%
Net margin11.5% vs 10.0%
Return on equity28.0% vs 12.0%
P/E30.0 vs 26.2